🔎 Trials Near Me

Gara Jalqabaatti › Hemophilia › California

Qorannoo klinikaalii Hemophilia California keessatti

Qorannoo 14 Hemophilia f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Regents of the University of California||UC Davis Health, Rancho Cordova
  • UC Davis Health, Sacramento
  • UC Davis Ambulatory Care Clinic, Sacramento
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT05568719

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

  • Children's Hospital Los Angeles- Site Number : 8400005, Los Angeles
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 fi ol · Dhiroota · Haaromfame 23-Ful-2026 · NCT06145373

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

  • UC Davis Cancer Center, Sacramento
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 59 · Dhiroota · Haaromfame 11-Ful-2026 · NCT05987449

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

  • Center for Inherited Blood Disorders, Orange
  • University of California San Francisco, San Francisco
  • Kaiser Permanente, Vallejo
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT07226206

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  • Center for Inherited Blood Disorders, Orange
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07416604

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 0 hanga 20 · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04278404

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Orthopaedic Institute for Children HTC, Los Angeles
  • Childrens Hospital Los Angeles, Los Angeles
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • fi 5 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

  • The Luskin Orthopaedic Institute for Children- Site Number : 8400013, Los Angeles
  • The Center for Inherited Blood Disorders- Site Number : 8400009, Orange
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 11 · Dhiroota · Haaromfame 17-Hag-2026 · NCT07285460

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

  • Stanford University, Palo Alto
  • Rady Children's Hospital, San Diego
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 6 hanga 19 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05022459

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  • Children's Hospital Los Angeles, Los Angeles
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT06349473

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

  • Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 74 · Dhiroota · Haaromfame 03-Wax-2026 · NCT06703606

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

  • The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD), Orange
  • Stanford University: Stanford Children's Health, Redwood City
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 0 hanga 90 · Saalaa hunda · Haaromfame 03-Elb-2026 · NCT05500807

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

  • Orthopaedic Institute for Children, Los Angeles
  • University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 12-Ama-2026 · NCT04647227

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

  • Orthopedic Institute for Children- Site Number : 8400009, Los Angeles
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 18-Sad-2025 · NCT06941870

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.